Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 69 | 1 | 69 | +1 |
| Shares | 8.13M | 148.6K | 8.20M | +212.6K (+2.7%) |
| Value | $10.2M | $187.2K | $13.2M | +$3.14M (+31.2%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gagnon Securities LLC | 226,622 | $364.9K | 0.08% |
| Nuveen, LLC | 148,560 | $239.2K | 0.00% |
| Callan Family Office, LLC | 23,603 | $38.0K | 0.00% |
| Avantax Advisory Services, Inc. | 14,491 | $23.3K | 0.00% |
| Price T Rowe Associates Inc | 12,785 | $21.0K | 0.00% |
| Simplex Trading, LLC | 2,966 | $4.00K | 0.00% |
| Pittenger & Anderson Inc | 341 | $550 | 0.00% |
| Investors Research Corp | 250 | $403 | 0.00% |
| The PNC Financial Services Group, Inc. | 220 | $354 | 0.00% |
| True Wealth Design, LLC | 17 | $28 | 0.00% |
Sold out (9)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Squarepoint Ops LLC | 183,262 | $230.9K |
| Millennium Management LLC | 117,454 | $148.0K |
| XTX Topco Ltd | 25,606 | $32.3K |
| PFG Investments, LLC | 18,250 | $23.0K |
| SG Americas Securities, LLC | 11,513 | $15.0K |
| Jain Global LLC | 10,831 | $13.6K |
| Bank of Jackson Hole Trust | 1,000 | $1.26K |
| BFSG, LLC | 500 | $630 |
| Citadel Advisors LLC | 298 | $375 |
Not filed for Q1 2025 yet (1)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 148,560 | $187.2K |